Literature DB >> 4075672

Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.

L Ramanna, A D Waxman, M B Brachman, D E Tanasescu, N Sensel, G D Braunstein.   

Abstract

Nineteen patients with differentiated thyroid carcinoma were given low dose (30 mCi) radioiodine therapy for the ablation of residual thyroid tissue following total thyroidectomy. Using 5- to 10-mCi diagnostic I-131 scans, ablation was achieved in two of 19 patients following the first low dose and three of 12 patients following the second low-dose therapy. The ablation response was 53% (ten of 19) following one large dose (100 mCi) in another concurrent group of 19 patients. The ablation response following the first low dose when compared with the first high-dose therapy was significantly lower (P = 0.015). The combined ablation response following first and second low doses (five of 14) when compared to a single large dose was not significantly different (P = 0.534). The use of low-dose-I-131 therapy, although not as effective as large dose therapy, may be warranted in patients resistant to entering the hospital for therapy. However, ablation as defined by a five- to ten-mCi I-131 scan can be expected to occur in only one third of the patients after two attempts at ablation, while a single 100-mCi regimen can be successful in achieving ablation in over one half of the patients after the first attempt.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075672     DOI: 10.1097/00003072-198511000-00009

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

1.  RADIOIODINE THERAPY FOR DIFFERENTIATED THYROID CARCINOMA : INHS ASVINI EXPERIENCE.

Authors:  J K Bhagat; Brig Dinesh Prasad
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 2.  Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited.

Authors:  Suhail A R Doi; Nicholas J Woodhouse; Lukman Thalib; Adedayo Onitilo
Journal:  Clin Med Res       Date:  2007-06

3.  A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.

Authors:  T Ben Ghachem; I Yeddes; I Meddeb; A Bahloul; A Mhiri; I Slim; M F Ben Slimene
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-25       Impact factor: 2.503

4.  I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence.

Authors:  Yan Shengguang; Choi Ji-Eun; He Li Lijuan
Journal:  Med Sci Monit       Date:  2016-07-13

5.  Evaluation of the dosimetry approaches in ablation treatment of thyroid cancer.

Authors:  Nalan Alan Selcuk; Turkay Toklu; Seval Beykan; Serife Ipek Karaaslan
Journal:  J Appl Clin Med Phys       Date:  2018-06-01       Impact factor: 2.102

6.  Determination and Comparison of Radiation Absorbed dose to the Blood, by Applying Different Techniques, for Patients, Suffering from Differentiated Thyroid Cancer.

Authors:  Issa Abdel-Rahman Al-Shakhrah
Journal:  Indian J Nucl Med       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.